2,627
Views
16
CrossRef citations to date
0
Altmetric
Ebola

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques

ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1635-1646 | Received 27 Apr 2022, Accepted 31 May 2022, Published online: 14 Jun 2022

References

  • Feldmann H, Sprecher A, Geisbert TW. Ebola. N Engl J Med. 2020;382(19):1832–1842. doi:10.1056/nejmra1901594.
  • Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol. 2018;3(10):1084–1089. doi:10.1038/s41564-018-0227-2.
  • Jahrling PB, Geisbert TW, Johnson ED, et al. Preliminary report: isolation of Ebola virus from monkeys imported to USA. The Lancet. 1990;335(8688):502–505. doi:10.1016/0140-6736(90)90737-P.
  • Cantoni D, Hamlet A, Michaelis M, et al. Risks posed by Reston, the forgotten ebolavirus. mSphere. 2016;1(6):e00322–16. doi:10.1128/msphere.00322-16.
  • Marsh GA, Haining J, Robinson R, et al. Ebola Reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis. 2011;204(suppl_3):S804–S8S9. doi:10.1093/infdis/jir300.
  • Forbes K, Webala P, Jääskeläinen A, et al. Bombali virus in Mops condylurus Bat, Kenya. Emerging Infectious Disease Journal. 2019;25(5):955. doi:10.3201/eid2505.181666.
  • WHO. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ. 1978;56(2):247–270.
  • Nicastri E, Kobinger G, Vairo F, et al. Ebola virus disease: epidemiology, clinical features, management, and prevention. Infect Dis Clin North Am. 2019;33(4):953–976. doi:10.1016/j.idc.2019.08.005.
  • Woolsey C, Geisbert TW. Current state of Ebola virus vaccines: a snapshot. PLoS Pathog. 2021;17(12):e1010078. doi:10.1371/journal.ppat.1010078.
  • Le Guenno B, Formenty P, Wyers M, et al. Isolation and partial characterisation of a new strain of Ebola virus. The Lancet. 1995;345(8960):1271–1274. doi:10.1016/s0140-6736(95)90925-7.
  • Ogawa H, Miyamoto H, Nakayama E, et al. Seroepidemiological prevalence of multiple species of filoviruses in fruit bats (Eidolon helvum) migrating in Africa. J Infect Dis. 2015;212(suppl 2):S101–S1S8. doi:10.1093/infdis/jiv063.
  • Wong G, He S, Wei H, et al. Development and characterization of a Guinea pig-adapted Sudan virus. J Virol. 2016;90(1):392–399. doi:10.1128/jvi.02331-15.
  • Brannan JM, Froude JW, Prugar LI, et al. Interferon α/β receptor–deficient mice as a model for Ebola virus disease. J Infect Dis. 2015;212(suppl 2):S282–SS94. doi:10.1093/infdis/jiv215.
  • Cross RW, Mire CE, Borisevich V, et al. The domestic Ferret (Mustela putorius furo) as a lethal infection model for 3 species of Ebolavirus. J Infect Dis. 2016;214(4):565–569. doi:10.1093/infdis/jiw209.
  • Kroeker A, He S, de La Vega M-A, et al. Characterization of Sudan ebolavirus infection in ferrets. Oncotarget. 2017;8(28):46262–46272. doi:10.18632/oncotarget.17694.
  • Geisbert TW, Strong JE, Feldmann H. Considerations in the use of nonhuman primate models of Ebola Virus and Marburg virus infection: table 1. J Infect Dis. 2015;212(suppl 2):S91–SS7. doi:10.1093/infdis/jiv284.
  • Zumbrun E, Bloomfield H, Dye J, et al. A Characterization of aerosolized Sudan virus infection in African Green monkeys, cynomolgus macaques, and Rhesus Macaques. Viruses. 2012;4(10):2115–2136. doi:10.3390/v4102115.
  • Matassov D, Mire CE, Latham T, et al. Single-dose trivalent VesiculoVax vaccine protects macaques from lethal ebolavirus and Marburgvirus challenge. J Virol. 2018;92(3). doi:10.1128/jvi.01190-17.
  • Cross RW, Xu R, Matassov D, et al. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. J Clin Invest. 2019;130(1):539–551. doi:10.1172/jci131958.
  • Milligan JC, Davis CW, Yu X, et al. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell. 2022;185(6):995–1007.e18. doi:10.1016/j.cell.2022.02.023.
  • Thi EP, Lee ACH, Geisbert JB, et al. Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nat Microbiol. 2016;1(10):16142. doi:10.1038/nmicrobiol.2016.142.
  • Gilchuk P, Murin CD, Cross RW, et al. Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 2021;184(22):5593–5607.e18. doi:10.1016/j.cell.2021.09.035.
  • Cross RW, Bornholdt ZA, Prasad AN, et al. Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease. JCI Insight. 2022. doi:10.1172/jci.insight.159090.
  • Kuang E, Cross RW, McCavitt-Malvido M, et al. Reversion of ebolavirus disease from a single intramuscular injection of a pan-ebolavirus immunotherapeutic. bioRxiv. 2022: doi:10.1101/2022.01.06.475142.
  • Woolsey C, Borisevich V, Agans KN, et al. Bundibugyo ebolavirus survival is associated with early activation of adaptive immunity and reduced myeloid-derived suppressor cell signaling. mBio. 2021;12(4):e0151721. doi:10.1128/mBio.01517-21.
  • Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337.
  • Heberle H, Meirelles GV, Da Silva FR, et al. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16(1). doi:10.1186/s12859-015-0611-3.
  • Wickham H. Ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2018.
  • Xu S, Chen M, Feng T, et al. Use ggbreak to effectively utilize plotting space to deal with large datasets and outliers. Front Genet. 2021;12; doi:10.3389/fgene.2021.774846.
  • Garnier S R, Noam R, Robert C, et al. Cédric viridis – colorblind-friendly color maps for R. Zenodo. 2021. doi:10.5281/zenodo.4679424. R package version 0.6.2, https://sjmgarnier.github.io/viridis/
  • McElroy AK, Erickson BR, Flietstra TD, et al. Biomarker correlates of survival in pediatric patients with Ebola Virus disease. Emerg Infect Dis. 2014;20(10). doi:10.3201/eid2010.140430.
  • McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis. 2014;210(4):558–566. doi:10.1093/infdis/jiu088.
  • Li G, Dai Y, Tan J, et al. SB203580 protects against inflammatory response and lung injury in a mouse model of lipopolysaccharide-induced acute lung injury. Mol Med Rep. 2020;22(2):1656–1662. doi:10.3892/mmr.2020.11214.
  • Okware SI, Omaswa FG, Zaramba S, et al. An outbreak of Ebola in Uganda. Trop Med Int Health. 2002;7(12):1068–1075. doi:10.1046/j.1365-3156.2002.00944.x.
  • Wauquier N, Becquart P, Padilla C, et al. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis. 2010;4(10):e837. doi:10.1371/journal.pntd.0000837.
  • Chomarat P, Banchereau J, Davoust J, et al. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 2000;1(6):510–514. doi:10.1038/82763.
  • Bray M, Geisbert TW. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol. 2005;37(8):1560–1566. doi:10.1016/j.biocel.2005.02.018.
  • Woolsey C, Jankeel A, Matassov D, et al. Immune correlates of postexposure vaccine protection against Marburg virus. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-59976-3.
  • Menicucci AR, Versteeg K, Woolsey C, et al. Transcriptome analysis of circulating immune cell subsets highlight the role of monocytes in Zaire Ebola Virus Makona pathogenesis. Front Immunol. 2017;8:1372. doi:10.3389/fimmu.2017.01372.
  • Lüdtke A, Ruibal P, Becker-Ziaja B, et al. Ebola virus disease is characterized by poor activation and reduced levels of circulating CD16+ monocytes. J Infect Dis. 2016;214(suppl 3):S275–Ss80. doi:10.1093/infdis/jiw260.
  • Kotliar D, Lin AE, Logue J, et al. Single-cell profiling of Ebola Virus disease in vivo reveals viral and host dynamics. Cell. 2020;183(5):1383–1401.e19. doi:10.1016/j.cell.2020.10.002.
  • Bowen ETW, Lloyd G, Harris WJ, et al. Viral Hæmorrhagic fever in Southern Sudan and Northern Zaire. The Lancet. 1977;309(8011):571–573. doi:10.1016/s0140-6736(77)92001-3.
  • Pierre D, Sanchez A. Blood chemistry measurements andd-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007;196(s2):S364–SS71. doi:10.1086/520613.
  • Geisbert TW, Young HA, Jahrling PB, et al. Mechanisms underlying coagulation abnormalities in Ebola Hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis. 2003;188(11):1618–1629. doi:10.1086/379724.